Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP815864.RAVdYYWjhMs-NOOBZRH0gz3JVlRZaHy02hiG8bChkdnnY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP815864.RAVdYYWjhMs-NOOBZRH0gz3JVlRZaHy02hiG8bChkdnnY130_assertion type Assertion NP815864.RAVdYYWjhMs-NOOBZRH0gz3JVlRZaHy02hiG8bChkdnnY130_head.
- NP815864.RAVdYYWjhMs-NOOBZRH0gz3JVlRZaHy02hiG8bChkdnnY130_assertion description "[Furthermore, our data show that pharmacological concentrations of celecoxib may interfere with the proapoptotic action of R(+)-MA and anandamide, suggesting that cotreatment with COX-2 inhibitors could diminish glioma regression induced by these compounds.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP815864.RAVdYYWjhMs-NOOBZRH0gz3JVlRZaHy02hiG8bChkdnnY130_provenance.
- NP815864.RAVdYYWjhMs-NOOBZRH0gz3JVlRZaHy02hiG8bChkdnnY130_assertion evidence source_evidence_literature NP815864.RAVdYYWjhMs-NOOBZRH0gz3JVlRZaHy02hiG8bChkdnnY130_provenance.
- NP815864.RAVdYYWjhMs-NOOBZRH0gz3JVlRZaHy02hiG8bChkdnnY130_assertion SIO_000772 15361550 NP815864.RAVdYYWjhMs-NOOBZRH0gz3JVlRZaHy02hiG8bChkdnnY130_provenance.
- NP815864.RAVdYYWjhMs-NOOBZRH0gz3JVlRZaHy02hiG8bChkdnnY130_assertion wasDerivedFrom befree-20140225 NP815864.RAVdYYWjhMs-NOOBZRH0gz3JVlRZaHy02hiG8bChkdnnY130_provenance.
- NP815864.RAVdYYWjhMs-NOOBZRH0gz3JVlRZaHy02hiG8bChkdnnY130_assertion wasGeneratedBy ECO_0000203 NP815864.RAVdYYWjhMs-NOOBZRH0gz3JVlRZaHy02hiG8bChkdnnY130_provenance.